en
Scientific article
English

Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review

Published inNew microbes and new infections, vol. 6, p. 1-4
Publication date2015
Abstract

The management of multidrug-resistant human immunodeficiency virus (MDR HIV) infections in children is particularly challenging due to the lack of experience with new drugs. Dolutegravir, combined with an optimized antiretroviral background therapy, is promising for the treatment of MDR HIV and has been approved recently for adults and adolescents. Data for children are extremely limited. We describe the efficacy, safety and plasmatic levels of a dolutegravir-based, complex active antiretroviral treatment regimen in a severely overweight 11-year-old child infected with an MDR HIV strain.

Citation (ISO format)
WAGNER, Noémie et al. Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review. In: New microbes and new infections, 2015, vol. 6, p. 1–4. doi: 10.1016/j.nmni.2015.02.003
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2052-2975
530views
1downloads

Technical informations

Creation09/08/2015 2:16:00 PM
First validation09/08/2015 2:16:00 PM
Update time03/14/2023 11:42:57 PM
Status update03/14/2023 11:42:57 PM
Last indexation01/16/2024 7:11:55 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack